Literature DB >> 18492535

Symptomatic pulmonary hypertension in a child with sickle cell disease.

Karrie Villavicencio1, Dunbar Ivy, Laura Cole, Rachelle Nuss.   

Abstract

Pulmonary hypertension is a survival-limiting complication in adults with homozygous sickle cell disease (SS), but little is known about the development, course, or best treatment of pulmonary hypertension in children with SS. We report the clinical course and treatment of a child with SS-associated, hemolysis-driven pulmonary hypertension.

Entities:  

Mesh：

Year:  2008        PMID： 18492535      PMCID： PMC3128440          DOI： 10.1016/j.jpeds.2008.01.042

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  10 in total

Review 1.  Pulmonary hypertension in sickle cell disease: mechanisms, diagnosis, and management.

Authors:  Oswaldo Castro; Mark T Gladwin
Journal:  Hematol Oncol Clin North Am       Date:  2005-10       Impact factor: 3.722

2.  Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease.

Authors:  Vandana Sachdev; Roberto F Machado; Yukitaka Shizukuda; Yesoda N Rao; Stanislav Sidenko; Inez Ernst; Marilyn St Peter; Wynona A Coles; Douglas R Rosing; William C Blackwelder; Oswaldo Castro; Gregory J Kato; Mark T Gladwin
Journal:  J Am Coll Cardiol       Date:  2007-01-16       Impact factor: 24.094

3.  Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.

Authors:  Gregory J Kato; Vicki McGowan; Roberto F Machado; Jane A Little; James Taylor; Claudia R Morris; James S Nichols; Xunde Wang; Mirjana Poljakovic; Sidney M Morris; Mark T Gladwin
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

4.  Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension.

Authors:  Roberto F Machado; Sabrina Martyr; Gregory J Kato; Robyn J Barst; Anastasia Anthi; Michael R Robinson; Lori Hunter; Wynona Coles; James Nichols; Christian Hunter; Vandana Sachdev; Oswaldo Castro; Mark T Gladwin
Journal:  Br J Haematol       Date:  2005-08       Impact factor: 6.998

5.  Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?

Authors:  Claudia R Morris; Sidney M Morris; Ward Hagar; Jane Van Warmerdam; Susan Claster; Diane Kepka-Lenhart; Lorenzo Machado; Frans A Kuypers; Elliott P Vichinsky
Journal:  Am J Respir Crit Care Med       Date:  2003-03-05       Impact factor: 21.405

Review 6.  Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension.

Authors:  Roberto F Machado; Mark T Gladwin
Journal:  Br J Haematol       Date:  2005-05       Impact factor: 6.998

7.  N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease.

Authors:  Roberto F Machado; Anastasia Anthi; Martin H Steinberg; Duane Bonds; Vandana Sachdev; Gregory J Kato; Angelo M Taveira-DaSilva; Samir K Ballas; William Blackwelder; Xiuli Xu; Lori Hunter; Bruce Barton; Myron Waclawiw; Oswaldo Castro; Mark T Gladwin
Journal:  JAMA       Date:  2006-07-19       Impact factor: 56.272

8.  Biological activity of nitric oxide in the plasmatic compartment.

Authors:  Xunde Wang; Jose E Tanus-Santos; Christopher D Reiter; Andre Dejam; Sruti Shiva; Reginald D Smith; Neil Hogg; Mark T Gladwin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-16       Impact factor: 11.205

9.  Clinical differences between children and adults with pulmonary hypertension and sickle cell disease.

Authors:  R Ward Hagar; Jennifer G Michlitsch; Jennifer Gardner; Elliott P Vichinsky; Claudia R Morris
Journal:  Br J Haematol       Date:  2007-10-03       Impact factor: 6.998

10.  Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

Authors:  Mark T Gladwin; Vandana Sachdev; Maria L Jison; Yukitaka Shizukuda; Jonathan F Plehn; Karin Minter; Bernice Brown; Wynona A Coles; James S Nichols; Inez Ernst; Lori A Hunter; William C Blackwelder; Alan N Schechter; Griffin P Rodgers; Oswaldo Castro; Frederick P Ognibene
Journal:  N Engl J Med       Date:  2004-02-26       Impact factor: 91.245
  10 in total
  2 in total

1.  Vascular risk assessment in patients with sickle cell disease.

Authors:  Claudia R Morris
Journal:  Haematologica       Date:  2011-01       Impact factor: 9.941

2.  Non-congenital heart disease associated pediatric pulmonary arterial hypertension.

Authors:  D D Ivy; J A Feinstein; T Humpl; E B Rosenzweig
Journal:  Prog Pediatr Cardiol       Date:  2009-12-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.